Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Hepatitis A Clinical Presentation and Management

  • In children younger than 6 years, more than 90% of hepatitis A infections are asymptomatic; when symptoms occur, they typically are not accompanied by jaundice, according to the American Academy of Pediatrics 3, 1
  • Among older children and adults, infection is typically symptomatic, with jaundice occurring in >70% of patients, as reported by the Centers for Disease Control and Prevention 1, 4

Clinical Course and Timeline

  • The average incubation period is 28 days (range: 15-50 days), with an initial presentation often including a 1-7 day prodromal illness with vague symptoms such as anorexia, malaise, fever, and nausea, as described by the American Academy of Pediatrics 3, 2, 1, 5, 6
  • Dark urine is often one of the first noticeable symptoms for which medical attention is sought, with feces becoming clay-colored and sclera, skin, and mucous membranes becoming jaundiced within days of bilirubinuria onset, according to the Centers for Disease Control and Prevention 3, 6, 5, 4

Infectivity Period

  • Peak infectivity occurs during the 2-week period before onset of jaundice or elevation of liver enzymes, with the virus being shed in stool and concentration declining after jaundice appears, as reported by the American Academy of Pediatrics and the Centers for Disease Control and Prevention 3, 1, 7
  • Children can shed the virus for longer periods than adults, up to 10 weeks after onset of clinical illness, while infants infected as neonates may shed the virus for up to 6 months, according to the Centers for Disease Control and Prevention 1, 5, 2

Complications

  • Approximately 10-15% of patients experience relapsing disease lasting up to 6 months, with about 20% of patients with relapsing disease having multiple relapses, as described by the American Academy of Pediatrics 3, 4, 8
  • Fulminant hepatitis A is rare but more common in people older than 50 years (case fatality rate reaches 1.8%) and patients with chronic liver disease, with an overall case-fatality ratio of approximately 0.3-0.6%, according to the Centers for Disease Control and Prevention 3, 1, 2

Diagnosis

  • Hepatitis A cannot be differentiated from other types of viral hepatitis based on clinical features alone, requiring serologic testing to detect IgM antibody to hepatitis A virus (IgM anti-HAV) to confirm acute infection, as recommended by the Centers for Disease Control and Prevention 1, 7, 2
  • In most persons, serum IgM anti-HAV becomes detectable 5-10 days before onset of symptoms, according to the American Academy of Pediatrics and the Centers for Disease Control and Prevention 1, 7